![]() |
Volumn 62, Issue 8, 2005, Pages 538-545
|
Perceptions of the impact of depression and anxiety and the medication for these conditions on safety in the workplace
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
CITALOPRAM;
CYCLOPENTHIAZIDE PLUS OXPRENOLOL;
DIAZEPAM;
DIURETIC AGENT;
DOSULEPIN;
DOXEPIN;
FLUOXETINE;
FLUPENTIXOL;
FLUVOXAMINE MALEATE;
IMIPRAMINE;
LI LIQUID;
LITHIUM CARBONATE;
LITHIUM CITRATE;
LORAZEPAM;
MIRTAZAPINE;
NEFAZODONE;
OXPRENOLOL;
PAROXETINE;
PINDOLOL;
PSYCHOTROPIC AGENT;
SERTRALINE;
TEMAZEPAM;
TRIPTAFEN;
TRIPTAFEN M;
VENLAFAXINE;
VISKALDIX;
ADULT;
ANXIETY DISORDER;
ARTICLE;
CONTROLLED STUDY;
DEPRESSION;
FEMALE;
HUMAN;
JOB ANALYSIS;
JOB PERFORMANCE;
MAJOR CLINICAL STUDY;
MALE;
OCCUPATIONAL HEALTH;
OCCUPATIONAL SAFETY;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SAFETY;
WORKPLACE;
ADOLESCENT;
ATTITUDE TO HEALTH;
HEALTH PERSONNEL ATTITUDE;
INFORMATION PROCESSING;
MIDDLE AGED;
OCCUPATIONAL ACCIDENT;
PERCEPTION;
STATISTICS;
TRAFFIC ACCIDENT;
UNITED KINGDOM;
ACCIDENTS, OCCUPATIONAL;
ACCIDENTS, TRAFFIC;
ADOLESCENT;
ADULT;
ANXIETY DISORDERS;
ATTITUDE OF HEALTH PERSONNEL;
ATTITUDE TO HEALTH;
DEPRESSIVE DISORDER;
ENGLAND;
FEMALE;
FOCUS GROUPS;
HUMANS;
MALE;
MIDDLE AGED;
OCCUPATIONAL HEALTH;
PERCEPTION;
PSYCHOTROPIC DRUGS;
SAFETY;
WORKPLACE;
|
EID: 23044436317
PISSN: 13510711
EISSN: None
Source Type: Journal
DOI: 10.1136/oem.2004.016196 Document Type: Article |
Times cited : (39)
|
References (20)
|